Predictors of Substance Abuse Identified among Teens with Bipolar Disorder
study in Journal of the American
Academy of Child and Adolescent Psychiatry
Reports new study in Journal of the American Academy of Child and Adolescent Psychiatry
Washington D.C., October 2, 2013
A study published in the October
2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry
found that approximately one in three teens with bipolar disorder developed
substance abuse, for the first time, during 4 years of follow-up. The study also
identified several risk factors that predicted who among these teens was most
likely to develop substance abuse.
Using data from the Course and Outcome of Bipolar Youth (COBY) study, a group of researchers led by Dr. Benjamin Goldstein, of the University of Toronto and the University of Pittsburgh, examined 167 youth, ages 12-17 years, to document the frequency and possible predictors of first-onset substance abuse. Participants in the study were interviewed an average of 7 times over the course of 4 years in order to examine their symptoms, functioning, stressors, and treatment.
The study found that 32% of adolescents in COBY developed abuse or dependence of alcohol or drugs, on average 2.7 years from the start of the study. Repeated experimentation with alcohol at the start of the study was the single strongest predictor of later substance abuse, although experimentation with cannabis also predicted later substance abuse. Five other factors present at the start of the study also predicted later substance abuse: oppositional defiant disorder, panic disorder, family history of substance abuse, low family cohesiveness, and absence of antidepressant treatment. Among teens with 3 or more risk factors, 54.7% went on to develop substance abuse, compared to 14.1% of teens with 0-2 risk factors.
The COBY study, funded by the National Institute of Mental Health, is the largest longitudinal study of children and adolescents with bipolar disorder. The 3-site study enrolled participants at Brown University, UCLA, and the University of Pittsburgh. COBY is continuing to follow these adolescents into their twenties and thirties.
Dr. Goldstein highlighted the risk associated with experimental substance use "in the case of adolescents with bipolar disorder, even so-called recreational substance use is playing with fire." He concluded "we appear to have this window of 2-3 years during which we can attempt to prevent substance abuse in these youth. This study provides some clues regarding the types of preventive strategies that may be useful."
The article "Predictors of First-Onset Substance Use Disorders During the Prospective Course of Bipolar Spectrum Disorders in Adolescents" by Benjamin I. Goldstein, Michael Strober, David Axelson, Tina R. Goldstein, Mary Kay Gill, Heather Hower, Daniel Dickstein, Jeffrey Hunt, Shirley Yen, Eunice Kim, Wonho Ha, Fangzi Liao, Jieyu Fan, Satish Iyengar, Neal D. Ryan, Martin B. Keller, and Boris Birmaher, (http://dx.doi.org/10.1016/j.jaac.2013.07.009) appears in the Journal of the American Academy of Child and Adolescent Psychiatry, Volume 52, Issue 10 (October 2013), published by Elsevier.
Funding: This research was supported by National Institute of Mental Health (NIMH) grants MH59929 (B.B.), MH59977 (M.S.), and MH59691 (M.B.K.), MH74945 (D.D.), MH69904 (S.Y.), and MH074581 (T.R.G.), and the Sunnybrook Foundation (B.I.G.)
# # #
Full text of the article is available to credentialed journalists upon request; contact Mary Billingsley at +1 202 966 7300 x105 or email@example.com. Journalists wishing to interview the authors may contact Benjamin Goldstein at firstname.lastname@example.org.
All articles published in JAACAP are embargoed until the day they are published as in press corrected proofs online at http://jaacap.org/inpress. Articles cannot be publicized as in press accepted manuscripts. Contents of the publication should not be released to or by the media or government agencies prior to the embargo date.
Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) is the official publication of the American Academy of Child and Adolescent Psychiatry. JAACAP is the leading journal focusing exclusively on today's psychiatric research and treatment of the child and adolescent. Published twelve times per year, each issue is committed to its mission of advancing the science of pediatric mental health and promoting the care of youth and their families.
The journal's purpose is to advance research, clinical practice, and theory in child and adolescent psychiatry. It is interested in manuscripts from diverse viewpoints, including genetic, epidemiological, neurobiological, cognitive, behavioral, psychodynamic, social, cultural, and economic. Studies of diagnostic reliability and validity, psychotherapeutic and psychopharmacological treatment efficacy, and mental health services effectiveness are encouraged. The journal also seeks to promote the well-being of children and families by publishing scholarly papers on such subjects as health policy, legislation, advocacy, culture and society, and service provision as they pertain to the mental health of children and families.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
JAACAP Editorial Office
+1 202 966 7300 x105